Year | Detail |
1998 |
MicroPort was founded in 1998 in a small office in ZJ Hi-Tech Park in Shanghai. |
2003 |
The company entered the Japanese market with PTCA Balloon dilatation catheters. |
2008 |
The company established Shanghai MicroPort Lifesciences Co., Ltd. and officially entered the diabetes business. |
2009 |
The company established Shanghai MicroPort Orthopedics Co., Ltd., a wholly-owned subsidiary at the Shanghai International Medical Zone headquartered in Suzhou. |
2011 |
Shanghai MicroPort Orthopedics Co., Ltd., a wholly-owned subsidiary, acquired Suzhou Best Co., Ltd., a domestic manufacturer and marketer of orthopedic implants and related medical instruments. |
2012 |
MicroPort Shanghai, a wholly-owned subsidiary of MicroPort Scientific Corp., acquired a 100% equity interest in Dongguan Kewei Medical Instrument Co. Ltd. This acquisition officially enters MicroPort Shanghai into the field of cardiac surgery. |
2014 |
MicroPort Scientific Corp. and Sorin Group have collaborated to make a definitive agreement to form a joint venture to market and develop cardiac rhythm management (CRM) devices in China. |
2014 |
The company acquired drug-eluting stent-related assets and intellectual properties from Cordis, which include formal Conor Medsystems, NEVO DES-related patents, and other intellectual property. |
2017 |
The company established MicroPort Urocare Co., Ltd., marking its official entry into the urology and gynecology sectors. |
2018 |
The company acquired the cardiac rhythm management business of LivaNova for $190 million in cash. |
2020 |
MicroImaging Medical Equipment Co., Ltd., a MicroPort and Siemens Healthineers subsidiary, jointly signed an agreement to develop Chinese-made digital subtraction angiography systems (DSAs). |
2020 |
MicroPort Scientific Corp. invested in Purple Medical Solutions Private Ltd. and established a joint venture company, Purple MicroPort Cardiovascular, in March 2020. |